HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shahrukh Hashmi Selected Research

Busulfan (Busulfex)

11/2021Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic Syndromes.
1/2020Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shahrukh Hashmi Research Topics

Disease

15Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2023 - 02/2016
12Neoplasms (Cancer)
11/2023 - 12/2019
10Myelodysplastic Syndromes (Myelodysplastic Syndrome)
11/2023 - 02/2016
9Graft vs Host Disease (Graft-Versus-Host Disease)
01/2023 - 01/2016
9Multiple Myeloma
01/2023 - 10/2014
7Hematologic Neoplasms (Hematological Malignancy)
11/2023 - 10/2022
6Bronchiolitis Obliterans Syndrome
10/2023 - 06/2014
4Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2023 - 01/2018
4Leukemia
01/2023 - 01/2018
4Infections
01/2021 - 01/2019
3Plasma Cell Leukemia
07/2021 - 12/2020
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
11/2023 - 01/2020
2Primary Myelofibrosis (Myelosclerosis)
01/2023 - 01/2023
2Hypogonadism (Hypergonadotropic Hypogonadism)
01/2022 - 01/2022
2Infertility (Sterility)
01/2022 - 01/2022
2COVID-19
01/2021 - 08/2020
1Frailty
10/2023
1Idiopathic Pulmonary Fibrosis
04/2023
1Liver Failure
01/2023
1Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
01/2023
1Hypophosphatemia
01/2023
1Hematologic Diseases (Blood Diseases)
01/2023
1Hypertension (High Blood Pressure)
01/2023
1Febrile Neutropenia
01/2023
1Cytopenia
06/2022
1T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic)
01/2022
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2022
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2022
1Lymphoma (Lymphomas)
01/2022
1Testicular Neoplasms (Testicular Cancer)
01/2022
1Breast Neoplasms (Breast Cancer)
12/2021
1Diabetic Ketoacidosis (Ketoacidosis, Diabetic)
12/2021
1Hemorrhage
05/2021
1Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria)
05/2021
1Thrombosis (Thrombus)
05/2021
1Epistaxis (Nosebleed)
05/2021
1Hemolysis
05/2021
1Chromosome Aberrations (Chromosome Abnormalities)
05/2021
1Uterine Hemorrhage (Uterine Bleeding)
05/2021
1Acute Disease
01/2021
1Blast Crisis (Blast Phase)
10/2020
1Fanconi Anemia (Fanconi's Anemia)
01/2020
1Pathologic Complete Response
01/2020
1Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
01/2019
1Sickle Cell Anemia (Hemoglobin S Disease)
11/2017

Drug/Important Bio-Agent (IBA)

3Melphalan (Alkeran)FDA LinkGeneric
01/2023 - 01/2020
3Lenalidomide (CC 5013)FDA Link
01/2023 - 02/2017
2Bortezomib (Velcade)FDA Link
01/2022 - 02/2017
2Dexamethasone (Maxidex)FDA LinkGeneric
01/2022 - 02/2017
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2022 - 02/2017
2fludarabineIBA
11/2021 - 01/2020
2Busulfan (Busulfex)FDA Link
11/2021 - 01/2020
2Alemtuzumab (Campath)FDA Link
01/2020 - 11/2015
2SteroidsIBA
01/2016 - 06/2014
2Fluorouracil (Carac)FDA LinkGeneric
02/2008 - 10/2006
2Capecitabine (Xeloda)FDA Link
02/2008 - 10/2006
1SenotherapeuticsIBA
04/2023
1Dasatinib (BMS 354825)FDA Link
04/2023
1QuercetinIBA
04/2023
1Azacitidine (5 Azacytidine)FDA Link
01/2023
1Cytarabine (Cytosar-U)FDA LinkGeneric
01/2023
1Daunorubicin (Cerubidine)FDA LinkGeneric
01/2023
1EnzymesIBA
01/2023
1sonidegibIBA
01/2023
1nilotinibFDA Link
01/2023
1Proteasome InhibitorsIBA
01/2023
1C-Reactive ProteinIBA
06/2022
1fibrin fragment D (D-dimer)IBA
06/2022
1OMS 2017IBA
06/2022
1Chimeric Antigen ReceptorsIBA
01/2022
1AlpelisibIBA
12/2021
1TeaIBA
05/2021
1ravulizumabIBA
05/2021
1eculizumabFDA Link
05/2021
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2021
1Nucleic AcidsIBA
08/2020
1Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
01/2020
1Tyrosine Kinase InhibitorsIBA
01/2020
1pegaspargase (Oncaspar)FDA Link
10/2019
1Methotrexate (Mexate)FDA LinkGeneric
10/2019
1Calcineurin InhibitorsIBA
01/2019
1CI 22IBA
01/2019
1AntigensIBA
01/2018
1HLA-C Antigens (HLA-C)IBA
01/2018
1Tacrolimus (Prograf)FDA LinkGeneric
01/2017

Therapy/Procedure

35Cell Transplantation
11/2023 - 02/2016
17Transplantation
11/2023 - 01/2019
13Therapeutics
01/2023 - 02/2008
7Hematopoietic Stem Cell Transplantation
01/2023 - 02/2017
6Stem Cell Transplantation
01/2023 - 10/2014
4Drug Therapy (Chemotherapy)
11/2023 - 03/2008
2Donor Selection
01/2023 - 03/2022
2Autologous Transplantation
01/2023 - 02/2017
1Artificial Respiration (Mechanical Ventilation)
06/2022
1MDC protocol
01/2022
1Homologous Transplantation
11/2021
1Platelet Transfusion (Blood Platelet Transfusions)
05/2021
1Activities of Daily Living (ADL)
01/2019
1Induction Chemotherapy
04/2016
1Contraindications
02/2016